G71.2
Congenital myopathies
Clinical Classification Guidelines
Excludes Type 2
- arthrogryposis multiplex congenita (Q74.3)
Medical Intelligence & Overview
Congenital myopathies are a group of rare genetic disorders characterized by muscle weakness that is present from birth or early childhood. These conditions impact the way muscles develop and function, often leading to difficulties with movement and muscle strength. Various types of congenital myopathies exist, each with unique features and severity levels, but all share the core characteristic of muscle impairment that can affect multiple areas of the body. Due to their genetic basis, these myopathies are typically diagnosed in infancy or early childhood, although some cases may present later. Understanding these conditions can help in managing their effects and providing appropriate support.
Causes & Symptoms
Clinical Causes: Genetic mutations inherited from parents or occurring de novo (new mutations) Mutations affecting genes that are crucial for muscle development and structure Variations in specific genes such as RYR1, SEPN1, and others involved in muscle fiber formation
Key Symptoms: Muscle weakness, especially in proximal muscles (near the trunk, such as shoulders and hips) Delayed motor milestones, like sitting, standing, or walking later than typical Hypotonia, characterized by reduced muscle tone (also known as 'floppy infant syndrome') Muscle wasting or loss of muscle mass over time Difficulty with movements such as climbing stairs, standing from a sitting position, or lifting objects In some cases, breathing difficulties due to weakened respiratory muscles Facial muscle weakness leading to expressive or swallowing issues
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical assessment, family history, and specialized tests, including: - Physical examination to evaluate muscle strength and tone - Electromyography (EMG) to assess electrical activity in muscles - Muscle biopsy to analyze muscle tissue structure and identify characteristic features - Genetic testing to detect specific mutations linked with congenital myopathies - Additional tests like MRI or blood enzyme levels may support diagnosis
Treatment Protocols: While there is currently no cure for congenital myopathies, management focuses on alleviating symptoms and enhancing quality of life. Approaches include: - Physical therapy to improve muscle strength, flexibility, and mobility - Occupational therapy to assist with daily activities - Respiratory support if breathing muscles are affected - Nutritional support to sustain overall health - Regular monitoring and follow-up with healthcare providers to address evolving needs - Emerging therapies and clinical trials are ongoing, offering hope for future treatment options
Clinical Advice & FAQs
Billing Guidance
Is G71.2 a billable ICD-10 code?
Yes, G71.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G71.2?
Clinical documentation must specify the nature of Congenital myopathies and any associated comorbidities for accurate reporting.
Cite this Clinical Reference